Lanean...
ADAURA: Mature Enough for Publication, Not for Prime Time
This commentary addresses the challenges related to using suboptimal endpoints to justify expedited approval of new drug therapies.
Gorde:
| Argitaratua izan da: | Oncologist |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley & Sons, Inc.
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8018310/ https://ncbi.nlm.nih.gov/pubmed/33314452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13637 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|